Evaluation of Hepatitis B screening and reactivation in patients receiving rituximab containing chemotherapy: A single-centre study.

Ilkay BozkurtHatun Ozturk CerikSeher KirMuge UstaogluMehmet TurgutSaban Esen

Published in: International journal of clinical practice (2021)

Incomplete screening and inappropriate prophylaxis may result in HBV reactivation in patients under RTX-based chemotherapy and related complications such as death.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
locally advanced
hepatitis b virus
peritoneal dialysis
diffuse large b cell lymphoma
risk factors
liver failure